Pulmatrix, Inc. revenue breakdown overview

Pulmatrix, Inc. revenue for the last year amounted to 7.30 M USD, the most of which — 7.30 M USD — came from its highest performing source at the moment, Novel Class of Inhaled Therapeutic Products, the year earlier bringing 6.07 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Pulmatrix, Inc. 7.30 M USD, and the year before that — 6.07 M USD.